AUG 20, 2026 · PHASE 2 TRIALRilonacept in Subjects With Cardiac SarcoidosisClinicalTrials.govPhase 2 interventional trial currently recruiting with no results posted; early-stage evidence in a rare disease with surrogate inflammatory endpoint.PreliminaryRilonaceptCardiac SarcoidosisNCT06660732ReportedPlanned enrollment60Study phasePhase 2Primary outcome measureChange in number of segments with FDG uptak…